Your browser doesn't support javascript.
loading
Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents.
Kamei, Koichi; Ogura, Masao; Sato, Mai; Nishi, Kentaro; Shoji, Kensuke; Funaki, Takanori; Ogimi, Chikara; Ito, Shuichi.
Afiliação
  • Kamei K; Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. kamei-k@ncchd.go.jp.
  • Ogura M; Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
  • Sato M; Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
  • Nishi K; Division of Nephrology and Rheumatology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
  • Shoji K; Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
  • Funaki T; Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
  • Ogimi C; Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
  • Ito S; Department of Pediatrics, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Pediatr Nephrol ; 38(4): 1099-1106, 2023 04.
Article em En | MEDLINE | ID: mdl-35913562

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Síndrome Nefrótica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Síndrome Nefrótica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article